title: Approaches to memory loss in neuropsychiatric disorders.
abstract: Many neuropsychiatric disorders affect memory. Brain regions important in the neuroanatomic substrate of memory include the hippocampus, and sections of the frontal, temporal, and parietal cortices and the thalamus. Acetylcholine and many other neurotransmitters and neuromodulators including dopamine, glutamate, GABA, the catecholamines, and estrogen modulate cognitive function. Treatment approaches to memory loss typically use Alzheimer's dementia as the template, and are discussed in this report.
authors: New York Memory and Health Aging Services, Department of Medicine, Division of Neurology, Lenox Hill Hospital, 65 East 76th Street, New York, NY 10021, USA. Gd@nymemory.org
authors: G
authors: G
authors: Devi
authors: J
authors: J
authors: Silver
mesh_terms: D000375:Aging / Q000523:psychology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003704:Dementia / Q000150:complications*; D000077265:Donepezil; D015914:Estrogen Replacement Therapy; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008569:Memory Disorders / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D018697:Nootropic Agents / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use; D017697:Premenopause / Q000523:psychology*; D016032:Randomized Controlled Trials as Topic; D013619:Tacrine / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D002800:Cholinesterase Inhibitors; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D013619:Tacrine; D000077265:Donepezil